Author Guidelines

I: GENERAL INFORMATION

A: Types of submissions

The Editors welcome the following types of papers:

Review Articles

A review article should:

  • Provide a comprehensive and critical review of the literature.
  • Provide a coherent view of the "state of the art" as it now stands
  • Provide a balanced overview of the current state of development of the area.
  • Emphasize and highlight the practical implications and educational message(s).
  • Be fully referenced, with all agents of relevance to the topic discussed in order to provide full coverage of the area.

Practical Applications

A practical application article should:

  • Review and explore the practicalities of implementing/using particular economic methodologies to address healthcare decision problems.
  • Either focus on one particular method and review its advantages and disadvantages, or focus more on a particular decision problem and review the various methods that might help inform the problem.

Original Research Articles

An original research article is a full length report of an original study or investigation. It should:

  • Clearly state the objective and study perspective.
  • Use appropriate methodology, outcomes measures etc.
  • Clearly and accurately report results, with sensitivity and statistical analyses performed as appropriate.
  • Provide a discussion that reviews the findings in light of other studies, and discusses the study limitations and generalisation of the findings.
  • Provide conclusions that follow logically from the results of the study.

Short Communications (word count up to 2000 plus any supplemental digital content)

A short communication is a short report describing preliminary research. The body of the manuscript should have the same elements as a full original research paper, but should be written in an abbreviated form and as concisely as possible.

Letters to the Editor (word count up to 1000)

A brief correspondence item commenting on an article published recently in the journal; a response to the comments would normally be sought from the authors of the original article and published in the same issue, where possible.

Editorial/Commentaries (word count up to 1500)

A brief opinion piece on a current topic of high interest.

Debate essays (word count up to 2000)

A debate essay assesses an area within the scholarly disciplines or policies pertinent to health.

B: Types of reporting guidelines

Randomized controlled trials

Randomized controlled trials should following the reporting guidelines specified in the CONSORT Statement (http://www.consort-statement.org). The appropriate extension to the CONSORT Statement should be referred to where relevant. Authors must provide (i) a copy of the ethics approval (or an explanation as to why ethics approval was not received) and, (ii) a completed CONSORT flowchart/checklist. Additionally, the clinical trial registration number should be included at the end of the abstract and should be quoted the first time the trial name is quoted in the paper.

Meta-analyses

Meta-analyses of randomized controlled trials should follow the reporting guidelines of PRISMA. Authors must provide a completed PRISMA flowchart and checklist (www.prisma-statement.org). Meta-analysis of observational studies should follow the reporting guidelines of MOOSE. Authors must provide a completed MOOSE checklist (www.equator-network.org/resource-centre/).

Observational studies

Observational studies (cohort, case-control, and cross-sectional studies) should follow the reporting guidelines of STROBE. Authors must provide the relevant completed STROBE checklist (www.strobe-statement.org).

II: PREPARING FOR SUBMISSION

Publication ethics Submissions to Journal of Market Access and Health Policy are considered on the understanding that the manuscript has been submitted exclusively to Journal of Market Access and Health Policy, that the data presented have not been published elsewhere, and that no additional submission will be made elsewhere unless the paper is rejected. Please inform editorial staff in your covering letter if your paper has previously been submitted to another journal and rejected; if this is the case you are required to provide the editorial/referee comments along with an explanation of how these comments have been addressed at the time of submission to Journal of Market Access and Health Policy.

Please note that the submitting author will be the principal contact for editorial correspondence, throughout the peer review and proofreading process, if applicable.

Plagiarism detection The publisher of Journal of Market Access and Health Policy, Co-Action Publishing, is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content items.

Co-Action Publishing uses iThenticate to screen all submissions for plagiarism before publication, but authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting http://research.ithenticate.com


Language All articles should be written in English - British or American as long as consistency is observed. SI units should be used. Please subject the manuscript to professional language editing before submitting the final version if you are not a native speaker. A list of services can be found here.

Competing interests and funding Authors are responsible for disclosing all relationships that could be viewed as potential conflicts of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. Please refer to the ICMJE statement on conflicts of interest (www.icmje.org/ethical_4conflicts.html).

Ethics and consent When reporting experiments on patients, please indicate whether the procedures followed were approved by your local ethics committee and/or in accordance with the Helsinki Declaration of 1975, as revised in 2008 (http://www.wma.net/en/30publications/10policies/b3/17c.pdf).

Acknowledgements List all contributors who do not meet the criteria for authorship, such as a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Financial and material support should also be acknowledged. Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under a heading such as 'clinical investigators' or 'participating investigators' and their function or contribution should be described.

Drug names Generic names (International Nonproprietary Names [INN]) must be used. In review papers, brand names or trade names can be used in selected instances, e.g. when use of the generic name would be impractical or ambiguous. In original research a therapeutic intervention should be named by both its generic name and trade name (along with the manufacturer and location) in the methods section in order to precisely identify the product investigated.

Abbreviations and symbols Use SI symbols and recognized abbreviations for units of measurement. The first time an abbreviation appears in the abstract and the text it should be preceded by the full name for which it stands, followed by the abbreviation in parentheses. Generally, abbreviations should be avoided as much as possible, and used only when the full term would make the text unduly cumbersome.

Publication fee See here.

WAIVER POLICY - please see here.


WITHDRAWAL OF MANUSCRIPT If you withdraw your manuscript after it has been peer reviewed, or after it has been typeset (but not yet published) you will be charged according to the following:

WITHDRAWAL OF MANUSCRIPT If you withdraw your manuscript after it has been typeset (but not yet published) you will be charged for the peer review and typesetting costs, EUR 225/USD 300 per article.

III: WRITING AND SUBMITTING YOUR PAPER

General Submitted manuscripts should follow the recommendations stated in Uniform requirements for manuscripts submitted to biomedical journals. Please review these guidelines. In addition, manuscripts submitted to Journal of Market Access and Health Policy should strictly follow the Guidelines provided below.

Use of word processing software It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc.
The electronic text should be prepared in a way very similar to that of conventional manuscripts. To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.

Keep all material together To facilitate the review process, please provide a complete manuscript as a text file (Word, RTF, WordPerfect) with all figures, tables, legends and supplementary material (if applicable) placed at the end of the manuscript after the reference list.

Submission procedure To submit your manuscript to the journal, just click on the "Submit manuscript" icon on this page, in the right-hand upper corner, and follow the step by step instructions. If for some reason you are unable to carry through this process, please contact support@co-action.net and we will help you, with no delay.

Article Structure Journal of Market Access and Health Policy publishes several categories of articles (see above) and, in their covering letter, authors should specify which one their contribution preferably belongs to.

Wherever possible, the paper should follow the traditional layout. Begin each section, including figure and table legends, on a new sheet; insert running page numbers.

Please do not number section headings. Use a maximum of three levels of headings made clear by orthographic indicators, i.e. capitals, italics, bold etc.

The title The title of the article should be informative and accurate and at the same time trigger the interest of the reader. A short running head will be derived from the title to appear on each page of the article.

Author names and affiliations Please indicate the first name(s) and surname(s) of each author. Surnames should be written in CAPITAL letters. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name.

Corresponding author Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address. Contact details must be kept up to date by the corresponding author.

Abstract The abstract should be concise and factual. It should state briefly the purpose of the research, the principal results and major conclusions. An abstract should provide sufficient information for a reader to be able to decide whether or not to proceed to the full text of the article. It is often presented separately from the article, so it must be able to stand alone. Avoid references in the abstract. Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention.

Authors of original research articles should follow a structured abstract in the following way:

  • Background (stating importance of the study question)
  • Objective (stating the precise objective)
  • Study design (basic design, years of the study and the years of follow-up)
  • Setting (e.g. general community, primary care, ambulatory or hospital care, etc.)
  • Patients or other participants (clinical disorder, major eligibility criteria, number of patients and how they were selected, details on matching of comparison groups if appropriate)
  • Intervention (essential features of any intervention, including method of delivery and duration of administration. The intervention should be named by its generic and trade name)
  • Main outcome measure (indicate the primary study outcome measurement[s] as planned before data collection began. State clearly if the hypothesis being tested was formulated during or after data collection)
  • Results (main outcomes of the study should be provided and quantified, including confidence intervals or p-values)
  • Conclusion (provide only conclusions of the study directly supported by the results, along with any implications for clinical practice, avoiding speculation and over-generalization).

Manuscripts reporting the results of meta-analyses should include an abstract using the following headings:

  • Background (a sentence or two explaining the importance of the review question)
  • Objective (state the precise primary objective of the review. Indicate whether the review emphasizes factors such as cause, diagnosis, prognosis, therapy, or prevention and include information about the specific population, intervention, exposure, and tests or outcomes that are being reviewed)
  • Data sources (succinctly summarize data sources, including years searched)
  • Study selection (describe inclusion and exclusion criteria used to select studies for detailed review from among studies identified as relevant to the topic. The method used to apply these criteria should be specified. State the proportion of initially identified studies that met selection criteria)
  • Data extraction (describe guidelines used for abstracting data and assessing data quality and validity. The method by which the guidelines were applied should be stated)
  • Data synthesis (state the main results of the review, whether qualitative or quantitative, and outline the methods used to obtain these results. Numerical results should be accompanied by confidence intervals, if applicable, and exact levels of statistical significance. Major identified sources of variation between studies should be stated, including differences in treatment protocols, co-interventions, confounders, outcome measures, length of follow-up, and dropout rates)
  • Conclusions (clearly state the conclusions and their applications [clinical or otherwise], limiting interpretation to the domain of the review)

Keywords Immediately after the abstract, please provide at least six keywords. Please avoid general and plural terms and multiple concepts (avoid, for example, "and", "of"), and also words already used in the title. Only abbreviations firmly established in the field are eligible. These keywords will be used for indexing purposes.

Artwork Upon acceptance please supply figures/graphics/images in at least 300 dpi. For further information please see guidelines.

If the figures/graphics/images have been taken from sources not copyrighted by the author, it is the author's sole responsibility to secure the rights from the copyright holder to reproduce those figures/graphs/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

When figures/graphics/images are reproduced, a parenthesis should be added to the figure legend thus: (Reproduced with permission from xxx.)

Reference style References should follow the standard biomedical format (so-called Vancouver style).

Number the references consecutively in the order in which they are first mentioned in the text. Identify references in the text by Arabic numerals and in parentheses, e.g. (14).The references should be listed numerically (not alphabetically) at the end of the manuscript as regular text.

Information from manuscripts submitted but not yet accepted should be cited in the text as 'unpublished observation(s)' or 'personal communication'.

General rules:
- Less than 6 authors: All authors' names (for first name(s), use only initials), followed by the title of the article, and the abbreviated name of the journal. Then add publication year, volume number, and page range - and/or DOI number, if available.

- More than 6 authors: first 6 authors' names (for first name(s), use only initials), followed by "et al.", followed by the title of the article, and the abbreviated name of the journal. Then add publication year, volume number, and page range - and/or DOI number, if available.

Examples of references:

►Reference to a Journal Publication

  1. Jaroslawski S, Toumi M. Design of patient access schemes in the UK: influence of health technology assessment by the National Institute for Health and Clinical Excellence. Appl Health Econ Health Policy. 2011; 9:209-15. doi: 10.2165/11592960-000000000-00000
  2. Kingma I, Ludwin D, Dandavino R, Wolff JL, Loertscher R, Beauregard-Zollinger L, et al. Economic analysis of Neoral in de novo renal transplant patients in Canada. Clin Transplant 1997;11:42-8.

For a key of how to abbreviate medical journal names, please consult the List of Journals Indexed in Index Medicus accessible at http://www.ncbi.nlm.nih.gov/sites/entrez?db=journals .

►Reference to a Book

  1. Crandall BC, Lewis J, editors. Nanotechnology: research and perspectives. Cambridge, Massachusetts: MIT Press, 1992.
  2. Baxter PS, Farnsworth TP. Social health and class inequalities. In: Carter C, Peel JR, editors. Equalities and inequalities in health. 2nd ed. London: Academic Press; 1976. p. 165-78.